The Worldwide Cannabis Industry is Projected to Reach $82.3 Billion by 2027 – Yahoo Finance

Share Article

DUBLIN, Oct. 21, 2022 /PRNewswire/ — The “Global Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, Balanced THC & CBD), Application (Medical, Recreational), and Region (North America, South America, Europe, RoW) – Forecast to 2027″ report has been added to’s offering.
The global cannabis market is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value.
The market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.
The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share.
By application, the recreational segment is projected to grow at the highest CAGR during the forecast period
Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.
By compound, the THC-dominant segment is estimated to account for the largest share
THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.
The European region is projected to grow at the highest CAGR during the forecast period
The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions.
As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Attractive Opportunities in Cannabis Market
4.2 Cannabis Market: Major Regional Submarkets
4.3 North America: Cannabis Market, by Compound and Country
4.4 Cannabis Market, by Application
4.5 Cannabis Market, by Compound
4.6 Cannabis Market, by Product Type and Region
5 Market Overview
5.1 Introduction
5.2 Macroeconomic Indicators
5.2.1 Increase in Aging Population
5.2.2 Economic Downturn
5.3 Market Dynamics
5.3.1 Drivers Rising Cannabis Demand for Medicinal Applications Legalization of Cannabis and Rise in Social Acceptance Growth in R&D Activities and Technological Advancements to be Precursors for Cannabis Business Rising Global Cannabis Sales Helping Online Retailers Expand
5.3.2 Restraints Complex Regulatory Structure for Use of Cannabis Problems Associated with High Dose of Cannabis Consumption Stigmatization of Cannabis Market Profit Margins of Manufacturers Shrinks as Cannabis Prices Fall
5.3.3 Opportunities Emergence of Cannabis Legalization in Asia-Pacific Edibles, Led by Gummies and Chocolates, to Present Additional Growth Opportunities for Cannabis Business Inorganic Growth Strategies Adopted by US Cannabis Companies
5.3.4 Challenges Intensive Water Consumption and Inability to Maintain Consistency During Cannabis Cultivation Cannabis-Producing Businesses Face Financing Difficulties in US Advertising and Marketing Restrictions in US Supply Chain Challenges Associated with Cannabis in US
6 Industry Trends
6.1 Introduction
6.2 Value Chain
6.2.1 Research and Product Development
6.2.2 Raw Material Sourcing
6.2.3 Production
6.2.4 Packaging, Storage, and Distribution
6.2.5 Retail
6.3 Supply Chain Analysis
6.4 Trends/Disruptions Impacting Customers’ Businesses
6.4.1 Revenue Shift and New Revenue Pockets in Cannabis Market
6.5 Market Mapping and Ecosystem of Cannabis Market
6.5.1 Demand-Side
6.5.2 Supply-Side
6.5.3 Ecosystem Map
6.6 Technology Analysis
6.6.1 Led Glow Light
6.6.2 Nanoencapsulation
6.6.3 Artificial Intelligence and Blockchain
6.6.4 Crop Steering
6.6.5 Vertical Farming
6.6.6 Innovative Hardware Tech Devices
6.6.7 IoT Automation
6.6.8 Genetic Engineering
6.7 Pricing Analysis
6.7.1 Selling Prices Charged by Key Players in Terms of Product Type
6.8 Cannabis Market: Patent Analysis
6.8.1 List of Major Patents
6.9 Trade Analysis: Cannabis Market
6.9.1 Export Scenario of Hemp
6.9.2 Import Scenario of Hemp
6.10 Case Studies: Cannabis Market
6.10.1 Filter420: Attempts to Build Brand Value
6.10.2 Onyx Agronomics: Precision Cannabis Facility
6.11 Key Conferences and Events, 2022-2023
6.12 Tariff and Regulatory Landscape
6.13 Porter’s Five Forces Analysis
6.14 Key Stakeholders and Buying Criteria
7 Cannabis Market, by Product Type
7.1 Introduction
7.2 Flowers
7.2.1 Automation and Sustainable Packaging to be Key Trends in Pre-Roll Domain
7.3 Concentrates
7.3.1 Various Delivery Methods Resulted in Consumer-Friendly Cannabis Concentrates Market
7.4 Edibles
7.4.1 Food and Beverage Manufacturing Companies Venture into Cannabis-Infused Edibles
7.5 Topicals & Tinctures
7.5.1 Topicals Witness Increased Demand in Skincare Industry
7.6 Other Product Types
8 Cannabis Market, by Compound
8.1 Introduction
8.2 Tetrahydrocannabinol (THC)-Dominant
8.2.1 Increasing Legalization of Recreational Cannabis Propels THC-Dominant Cannabis Market
8.3 Cannabidiol (CBD)-Dominant
8.3.1 Increased Popularity of CBD Edibles to Drive CBD-Dominant Cannabis Products Market
8.4 Balanced THC & CBD
8.4.1 Balanced THC & CBD Strains Witness Growth as CBD Diminishes Psychoactive Properties of THC
9 Cannabis Market, by Application
9.1 Introduction
9.2 Medical
9.2.1 Increase in Cannabis Use for Treatment of Various Ailments Drives Demand for Medical Cannabis Pain Management Neurological Health Management Mental Health Management Other Medical Applications
9.3 Recreational
9.3.1 Wider Legalization Status of Recreational Cannabis to Boost Market Growth
10 Cannabis Market, by Region
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2021
11.3 Segmental Revenue Analysis of Key Players
11.4 Key Player Strategies
11.5 Company Evaluation Quadrant (Key Players)
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Product Footprint
11.6 Cannabis Market: Evaluation Quadrant for Startups/SMEs, 2021
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
11.6.5 Competitive Benchmarking of Key Startups/SMEs
11.7 Product Launches, Deals, and Other Developments
11.7.1 Product Launches
11.7.2 Deals
11.7.3 Others
12 Company Profiles
12.1 Introduction
12.2 Key Players
12.2.1 Canopy Growth Corporation
12.2.2 Curaleaf
12.2.3 Cresco Labs
12.2.4 Green Thumb Industries
12.2.5 Tilray
12.2.6 Trulieve
12.2.7 Aurora Cannabis Inc.
12.2.8 Medmen
12.2.9 Unrivaled Brand Inc.
12.2.10 Organigram Holdings Inc.
12.2.11 Stenocare
12.2.12 Vivo Cannabis Inc.
12.2.13 Terrascend
12.2.14 Hexo Corp
12.2.15 Village Farms International Inc.
12.2.16 Verano
12.3 Other Players (SMEs/Startups)
12.3.1 The Cronos Group
12.3.2 Medical Marijuana, Inc.
12.3.3 Ecofibre Limited
12.3.4 Indiva
12.3.5 Tikun Olam-Cannbit Pharmaceuticals Ltd.
12.3.6 Maricann Group Inc.
12.3.7 Satipharm
12.3.8 Cannabliss Organic LLC
12.3.9 Connected Cannabis Co.
12.3.10 Justice Cannabis Co.
12.3.11 Henry’s Original
13 Appendix
For more information about this report visit
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:–301656144.html
SOURCE Research and Markets
Private Bancorp of America, Inc. (PBAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
401(k) contribution limits for 2023 follow a big bump to tax brackets and the size of the standard deduction
The Gaithersburg vaccine maker has earned the Centers for Disease Control and Prevention’s recommendation to make its protein-based shot available as a booster to adults in the U.S., the last hurdle required before people can use it beyond a primary series. The CDC said late Wednesday that its director, Dr. Rochelle Walensky, greenlit the decision — which gives initially vaccinated adults the choice to get Novavax’s jab as a booster instead of the updated Omicron-specific shots from Pfizer-BioNTech or Moderna. Novavax’s vaccine instead uses a decades-old technology found in vaccines for viruses such as flu and whooping cough, which the company is hoping will spur demand from people unable to, or who choose not to, receive the newer mRNA vaccines.
Millions of Americans can save more in retirement accounts next year, after inflation adjustments made by the Internal Revenue Service.
The possibility of a recession complicates the picture for disengaged workers, a Conference Board survey found.
Exxon Mobil Corp shares passed their all-time high on Friday as oil prices resumed their climb and analysts raised their long-term views of top U.S. oil producer's cash flow and earnings outlook. Exxon is leading a parade of record profits among oil majors this year after doubling down on oil during the pandemic, when energy prices fell to a two-decade low and European oil majors slashed spending and moved further to renewable projects. The rally comes as vindication for Chief Executive Darren Woods, who as oil prices fell in 2020 decided to "lean in" to oil investments.
It leaves the U.S. with an emergency supply that will only last for 20 days.
Pinterest will release financial results for the third quarter 2022 on Thursday, October 27, after market close. Bottom-line strategy: It looks like bullish traders are shying away from PINS ahead of earnings.
Few high-profile money managers have a nose for making money quite like Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. In the 57 years since taking the reins, the Oracle of Omaha, as he's come to be known, has led his company's Class A shares (BRK.A) to a jaw-dropping average annual return of 20.1%. The Oracle of Omaha believes diversification is "protection against ignorance."
Financial services giant Fidelity has a rule for retirement savings you may have heard of: Have 10 times your annual salary saved for retirement by age 67. This oft-cited guideline can help you identify a retirement savings goal, but it … Continue reading → The post Should the 45% Rule Guide Your Retirement Strategy? appeared first on SmartAsset Blog.
Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced an extension of its Ace Valley brand portfolio with the launch of Lust Cherry Rose and Thrust Watermelon Goji. These two new, distinctly-flavoured, gummies are the first of their kind in the Canadian market, celebrating the intersection of cannabis and sex positivity by empowering consumers to enhance their pe
Kroger Co. has unveiled what it’s calling its "store of the future" Thursday, testing the concept in Greater Cincinnati.
More than 160 people are losing their jobs as Meta cuts back on its once-ubiquitous tech bus shuttles.
We’re in a volatile bear market right now, and key riddle investors need to answer is, which stocks are going to bring the best returns, even in today’s uncertain conditions. One market segment that can’t be ignored is the low-cost penny stocks. These equities, typically priced under $5 per share, offer the best combination of risk and reward: a minimal cost of entry, and frequently triple-digit upside potential. Going beyond the argument that you get more for your money, even minor price apprec
(Bloomberg) — Schlumberger shares soared after posting its best profit in seven years and raising guidance for the rest of 2022 as overseas drillers put oil and gas rigs back to work, following North America’s lead amid tight global supplies. Most Read from BloombergTwitter Tumbles as US Weighs Security Reviews for Musk DealsTrump Deposed in Suit by Investors Claiming Fraud in ‘Apprentice’ Videophone PitchesTranscript: Nouriel Roubini Predicts a Crisis 'Worse' Than the 1970sLiz Truss Odds: The
Picking the right markets to compete in makes surviving bear markets much more manageable for these companies.
Verizon Communications Inc. on Friday unveiled a new cost-cutting plan after higher corporate costs and rising interest rates ate into its third-quarter profit. The largest U.S. cellphone carrier in terms of subscribers reported a net gain of 8,000 phone connections under postpaid billing plans during the September quarter, a sign that recent rate increases had prompted many of its most reliable customers to leave the service. Verizon executives nevertheless said that the price increases for certain cellphone plans were paying off, noting that overall wireless service revenue grew over the third quarter.
The chief executive of Vale SA said on Friday the Brazilian iron ore miner is reconsidering a near-term spin-off of its base metals business and an eventual public listing. But rather than selling all or part of it, the company is now looking to separate and ring-fence the copper and nickel unit from the iron ore business as the two have different growth prospects, Eduardo Bartolomeo said at the FT Mining Summit. The idea is to eventually grow the base metals unit as big as Vale today, which has a market capitalisation of $66 billion, and take it to the public market, Bartolomeo said, without giving details on timing.
Alzheimer's therapies are big news lately. The disease is the leading cause of dementia and memory loss. The Alzheimer's Association estimates that 6.5 million Americans 65 and older are living with Alzheimer's dementia (AD) and by 2050, the number of people 65 and older with AD is projected to reach 12.7 million.
Today, most of the people who wanted the primary vaccine series have gotten it. Of course, all of this is unlikely to lead to a huge jump this year in the numbers of people opting for strain-specific boosters.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort